SCHEMBL5515664

SCHEMBL5515664

CCCCCCCCCOC(=O)C1CC=CCC1C(=O)OCCCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.48
EPHX1 P07099 1/20 0.46
PPARG P37231 3/20 0.46
TSHR P16473 4/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
POLB P06746 1/20 0.44
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42
RAD52 P43351 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31321935 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1
SCHEMBL5513466 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1
SCHEMBL31321936 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1
SCHEMBL5515217 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1
SCHEMBL1169497 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1
SCHEMBL5516928 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1
SCHEMBL5516717 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1
SCHEMBL1170278 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1
SCHEMBL5522842 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1
SCHEMBL31321918 1.00 NAAA (0.48) NAAAEPHX1PPARGTSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3238690-B1 BAG FOR MEDICAL USE KAWASUMI LAB INC (JP) 2022-09-14 EP claimed
EP-3238690-A1 BAG FOR MEDICAL USE Kawasumi Laboratories, Inc. (JP) 2017-11-01 EP claimed
EP-3238690-B1 BAG FOR MEDICAL USE KAWASUMI LAB INC (JP) 2022-09-14 EP disclosed
EP-3238690-A1 BAG FOR MEDICAL USE Kawasumi Laboratories, Inc. (JP) 2017-11-01 EP disclosed
EP-3238690-A1 BAG FOR MEDICAL USE Kawasumi Laboratories, Inc. (JP) 2017-11-01 EP disclosed
WO-2016121692-A1 BAG FOR MEDICAL USE 川澄化学工業株式会社 2016-08-04 WO disclosed
US-7282601-B2 Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester NEW JAPAN CHEMICAL CO., LTD. (JP) 2007-10-16 US disclosed
US-20050038283-A1 Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester NEW JAPAN CHEMICAL, CO., LTD. (JP) 2005-02-17 US disclosed
US-6667285-B1 Branched-chain carboxylic acid monoalkyl ester with outstanding hydrolytic stability NEW JAPAN CHEMICAL CO., LTD. (JP) 2003-12-23 US disclosed
EP-1227078-A1 DICARBOXYLIC DIESTER, PROCESS FOR PRODUCING THE SAME, AND REFRIGERATING MACHINE LUBRICATING OIL COMPRISING THE ESTER NEW JAPAN CHEMICAL CO.,LTD. (JP) 2002-07-31 EP disclosed
EP-1225213-A1 LUBRICATING OIL FOR REFRIGERATOR, HYDRAULIC FLUID COMPOSITION FOR REFRIGERATOR AND METHOD FOR LUBRICATION OF REFRIGERATOR NEW JAPAN CHEMICAL CO.,LTD. (JP) 2002-07-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038283-A1 Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester SCO2, PDHX, DECR2 NAAA 2759/4885EPHX1 279/4885PPARG 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.